Biomarkers can help with basic understanding of breast cancer

Joyce O'Shaughnessy, a researcher at Baylor Sammons Cancer Center in Dallas, is interviewed by OncLive about the future of breast cancer biomarkers. O'Shaughnessy says that because of the complex "systems biology" nature of breast cancer, it might not be possible to know "every operative pathway and microenvironment." But biomarkers can help with a basic understanding of the biology. She encourages discovery of biomarkers that exclude some patients from studies if they indicate they will not be responsive. O'Shaughnessy also says the focus should not be on so many narrow subsets of patients, but breast cancer biomarkers should apply to a broader range of patients. Story and video

Suggested Articles

Abbott launched a rapid coronavirus test able to deliver positive results in as little as five minutes, from a table-top box the size of a toaster.

The FDA will be working with government and public-private partners to distribute and evaluate 3D designs and models.

The FDA issued a wide-ranging emergency policy allowing alternative devices to be used as potentially lifesaving ventilators amid new shortages.